|
03 Sep 2025 |
Krishna Institute
|
Consensus Share Price Target
|
737.60 |
779.46 |
- |
5.68 |
buy
|
|
|
|
|
08 Aug 2024
|
Krishna Institute
|
Edelweiss
|
737.60
|
2560.00
|
2191.50
(-66.34%)
|
Target met |
Buy
|
|
|
Capacity expansion to drive growth
|
|
18 Jun 2024
|
Krishna Institute
|
Prabhudas Lilladhar
|
737.60
|
2200.00
|
2040.10
(-63.84%)
|
Target met |
Buy
|
|
|
|
|
06 Jun 2024
|
Krishna Institute
|
Geojit BNP Paribas
|
737.60
|
2164.00
|
1884.25
(-60.85%)
|
Target met |
Accumulate
|
|
|
|
|
20 May 2024
|
Krishna Institute
|
Edelweiss
|
737.60
|
2193.00
|
1952.20
(-62.22%)
|
Target met |
Buy
|
|
|
Capacity expansion to drive growth
|
|
19 May 2024
|
Krishna Institute
|
ICICI Securities Limited
|
737.60
|
2315.00
|
1952.20
(-62.22%)
|
Target met |
Buy
|
|
|
Krishna Institute of Medical Sciences’ (KIMS) Q4FY24 was below our expectations. One-off refurbishment charge of INR 100mn and higher depreciation of Sunshine Begumpet hospital led to this miss.
|
|
18 May 2024
|
Krishna Institute
|
Axis Direct
|
737.60
|
2100.00
|
1952.20
(-62.22%)
|
Target met |
Buy
|
|
|
We have BUY on stock
|
|
06 Feb 2024
|
Krishna Institute
|
Axis Direct
|
737.60
|
2300.00
|
2133.60
(-65.43%)
|
Target met |
Buy
|
|
|
The Q3FY24 occupancies revealed occupancy softness in KIMS matured hospitals, which constitute 60% of its Telangana and AP revenue. Recommendation BUY
|
|
05 Feb 2024
|
Krishna Institute
|
Prabhudas Lilladhar
|
737.60
|
2200.00
|
2092.90
(-64.76%)
|
Target met |
Buy
|
|
|
|
|
15 Nov 2023
|
Krishna Institute
|
Geojit BNP Paribas
|
737.60
|
2136.00
|
1895.35
(-61.08%)
|
Target met |
Accumulate
|
|
|
|
|
09 Nov 2023
|
Krishna Institute
|
Axis Direct
|
737.60
|
2100.00
|
1889.00
(-60.95%)
|
Target met |
Buy
|
|
|
We have BUY on the stock
|